SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-14-005434
Filing Date
2014-11-10
Accepted
2014-11-10 17:10:52
Documents
11
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q ptla-10q_20140930.htm 10-Q 1752053
2 EX-10.24 ptla-ex1024_20140930276.htm EX-10.24 535288
3 EX-31.1 ptla-ex311_20140930277.htm EX-31.1 14404
4 EX-31.2 ptla-ex312_20140930278.htm EX-31.2 14397
5 EX-32.1 ptla-ex321_20140930279.htm EX-32.1 7993
  Complete submission text file 0001564590-14-005434.txt   8255912

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT ptla-20140930.xml EX-101.INS 1330145
7 XBRL TAXONOMY EXTENSION SCHEMA ptla-20140930.xsd EX-101.SCH 39220
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ptla-20140930_cal.xml EX-101.CAL 34042
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ptla-20140930_def.xml EX-101.DEF 94384
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE ptla-20140930_lab.xml EX-101.LAB 288239
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ptla-20140930_pre.xml EX-101.PRE 207199
Mailing Address 270 EAST GRAND AVENUE, SUITE 22 SOUTH SAN FRANCISCO CA 94080
Business Address 270 EAST GRAND AVENUE, SUITE 22 SOUTH SAN FRANCISCO CA 94080 650-244-6864
PORTOLA PHARMACEUTICALS INC (Filer) CIK: 0001269021 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35935 | Film No.: 141209690
SIC: 2834 Pharmaceutical Preparations